Search

Your search keyword '"Esophageal Achalasia metabolism"' showing total 73 results

Search Constraints

Start Over You searched for: Descriptor "Esophageal Achalasia metabolism" Remove constraint Descriptor: "Esophageal Achalasia metabolism"
73 results on '"Esophageal Achalasia metabolism"'

Search Results

1. Biallelic NDC1 variants that interfere with ALADIN binding are associated with neuropathy and triple A-like syndrome.

2. Focus on Achalasia in the Omics Era.

3. SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome.

4. Scoping Review and Bibliometric Analysis of the Most Influential Publications in Achalasia Research from 1995 to 2020.

5. Esophagogastric junction outflow obstruction: Characterization of a new entity? Clinical, manometric, and neuroimmunological description.

6. Allgrove Syndrome: A Report of New Pathological Variants in the AAAS Gene.

7. Aflatoxin influences achalasia symptomatology.

8. Triple-A Syndrome (TAS): An In-Depth Overview on Genetic and Phenotype Heterogeneity.

9. Loss of the nucleoporin Aladin in central nervous system and fibroblasts of Allgrove Syndrome.

10. Isolated glucocorticoid deficiency: Genetic causes and animal models.

11. Characterization of esophageal inflammation in patients with achalasia. A retrospective immunohistochemical study.

12. Calcium Receptor and Nitric Oxide Synthase Expression in Circular Muscle of Lower Esophagus from Patients with Achalasia.

13. Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice.

14. INPP4B overexpression and c-KIT downregulation in human achalasia.

15. Triple-A syndrome: a wide spectrum of adrenal dysfunction.

16. c-Abl regulates gastrointestinal muscularis propria homeostasis via ERKs.

17. Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.

18. The nucleoporin ALADIN regulates Aurora A localization to ensure robust mitotic spindle formation.

19. Reduction of hydrogen sulfide synthesis enzymes in the esophagus of patients with achalasia: effect of hydrogen sulfide in achalasia.

20. The muscular expression of RAS in patients with achalasia.

21. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.

22. Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis.

23. Smooth muscle fascicular reorientation is required for esophageal morphogenesis and dependent on Cdo.

24. An imbalance between substance P and vasoactive intestinal polypeptide might contribute to the immunopathology of megaesophagus after Trypanosoma cruzi infection.

25. Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress.

26. Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis.

27. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.

28. Intracellular ROS level is increased in fibroblasts of triple A syndrome patients.

29. Oesophageal 131I uptake in a patient with achalasia.

30. Triple A syndrome: 32 years experience of a single centre (1977-2008).

31. Expression of p53 as predictor for the development of esophageal cancer in achalasia patients.

32. Expression of ki-67 antigen and caspase-3 protein in benign lesions and esophageal carcinoma.

33. Triple A syndrome: a novel compound heterozygous mutation in the AAAS gene in an Italian patient without adrenal insufficiency.

34. Triple-A syndrome.

35. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism.

36. Megaoesophagus in Rassf1a-null mice.

37. kDNA gene signatures of Trypanosoma cruzi in blood and oesophageal mucosa from chronic chagasic patients.

38. Restoration of nuclear-import failure caused by triple A syndrome and oxidative stress.

39. Patterns of esophageal acid exposure after laparoscopic Heller's myotomy and Dor's fundoplication for esophageal achalasia.

40. Very long-term objective evaluation of heller myotomy plus posterior partial fundoplication in patients with achalasia of the cardia.

41. Myosin heavy chain composition and fiber size of the cricopharyngeus muscle in patients with achalasia and normal subjects.

42. p53 and MIB-1 expression of esophageal carcinoma concominant with achalasia.

43. Reduced expression of Ca2+-regulating proteins in the upper gastrointestinal tract of patients with achalasia.

44. Laparoscopic Heller myotomy with Toupet fundoplication for achalasia straightens the esophagus and relieves dysphagia.

45. Achalasia of the cardia in Allgrove's (triple A) syndrome: histopathologic study of 10 cases.

46. The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity.

47. Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.

48. Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia.

49. Metabolic and immunologic consequences of laparoscopy with helium or carbon dioxide insufflation: a randomized clinical study.

50. Repetitive proximal esophageal contractions: a new manometric finding and a possible further link between Parkinson's disease and achalasia.

Catalog

Books, media, physical & digital resources